Exploiting the Endogenous Ubiquitin Proteasome System in Targeted Cancer Treatment.

Hauser, Noa; Hirbawi, Joud; Saban Golub, Meshi; Zabit, Samar; Lichtenstein, Michal; Lorberboum-Galski, Haya

Hauser, Noa; Hirbawi, Joud; Saban Golub, Meshi; Zabit, Samar; Lichtenstein, Michal; Lorberboum-Galski, Haya.

Afiliación

Hauser N; Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Hirbawi J; Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Saban Golub M; Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Zabit S; Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Lichtenstein M; Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Lorberboum-Galski H; Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.

Cancers (Basel) ; 15(1)2022 Dec 30.

Article en En | MEDLINE | ID: mdl-36612252

Palabras clave

HECT E3 ligase; IL-2; IL-2R; Smurf2; chimeric proteins; targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google